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ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comCORRESPONDENCEPlasma B-type natriuretic peptide in predicting
outcomes of elective coronary artery bypass
surgery (Reply)Dear Dr. Balta et al.:
Thank you for your comments about thearticle “PlasmaB-type
natriuretic peptide in predicting outcomes of elective coro-
nary artery bypass surgery”. The B-type natriuretic peptide
(BNP) is a neurohormone that is mainly secreted from the
cardiac left and right ventricles by increasing ventricular wall
stress and volume expansion. As youmentioned, high levels of
plasma natriuretic peptide and N-terminal proBNP (NT-
proBNP) have been reported in many conditions, such as fe-
male sex, old age, impaired renal function, hypertension,
pulmonaryhypertension, and heart failure [1,2]. However, the
inclusion criterion for the article was elective coronary artery
bypass surgery. Patients reported in the article were in more
stable condition. Bad conditions, such as sepsis, liver cirrhosis,
hyperthyroidism, interstitial lung disease, pulmonary embo-
lism, and uremia were excluded from this study. This study
demonstrated that old age, impaired renal function, and
postoperative day1 BNP and NT-proBNP could influence pro-
longed intensive care unit stay and hospitalization [3].
However, the correlation became insignificant after adjusting
for age, sex, renal function, and left ventricular function.
Advanced age revealed good correlations with prolonged
intensive care unit stay and hospitalization in both univariate
and multivariate logistic regression models. In clinical prac-
tice, we agree with you that one should keep in mind that BNP
alone without other predictive markers may not give exact
information to clinicians about prognostic indications.
References
[1] Valli N, Gobinet A, Bordenave L. Review of 10 years of the
clinical use of brain natriuretic peptide in cardiology. J Lab Clin
Med 1999;134:437e44.1607-551X/$36 Copyright ª 2013, Kaohsiung Medical University. Publish
http://dx.doi.org/10.1016/j.kjms.2013.09.010[2] McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I,
Morrison CE, et al. Biochemical detection of left ventricular
systolic dysfunction. Lancet 1998;351:9e13.
[3] Chen TH, Lin CL, Shih JM, Shih YM, Chen CH, Chang ML, et al.
Plasma B-type natriuretic peptide in predicting outcomes of
elective coronary artery bypass surgery. Kaohsiung J Med Sci
2013;29:254e8.
Thay-Hsiung Chen
Division of Cardiac Surgery, Cathay General Hospital,
Taipei, Taiwan
Ching-Ling Lin
Division of Endocrinology, Cathay General Hospital,
Taipei, Taiwan
Joseph Jaey-Ming Shih
James Yao-Ming Shih
Division of Cardiac Surgery, Cathay General Hospital,
Taipei, Taiwan
Chung-Huo Chen
Mei-Ling Chang
Chih-Hui Chin*
Division of Cardiology, Cathay General Hospital,
Taipei, Taiwan*Corresponding author. Division of Cardiology, Department
of Medicine, Cathay General Hospital, 280, Section 4,
Ren-Ai Road, 106 Taipei, Taiwan.
E-mail address: chchin@cgh.org.tw (C.-H. Chin)ed by Elsevier Taiwan LLC. All rights reserved.
